Related Experiment Video
Updated: Jul 14, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest
L Schneider1, F Essmann, A Kletke
1Institut für Biochemie und Molekularbiologie II, Universitätsklinikum der Heinrich-Heine-Universität, Düsseldorf, Germany.
Abstract:
Regulators of the mitotic spindle apparatus are attractive cellular targets for antitumor therapy. The centrosomal protein transforming acidic coiled coil (TACC) 3 is required for spindle assembly and proper chromosome segregation. In this study, we employed an inducible RNA interference approach to downregulate TACC3 expression. We show that TACC3 knock-down in NIH3T3 fibroblasts caused aneuploidy, but failed to overtly impair mitotic progression. TACC3 depletion rather triggered a postmitotic p53-p21(WAF) pathway and led to a reversible cell cycle arrest. Similar effects were induced by low concentrations of paclitaxel, a spindle poison used in antitumor therapy. Interestingly, however, and unlike in TACC3-proficient cells, paclitaxel was able to induce strong polyploidy and subsequent apoptosis in TACC3-depleted cells. Even though paclitaxel treatment was associated with the activation of the survival kinase Akt and an antiapoptotic expression of cytoplasmic p21(WAF) and cyclin D1, this inhibition of cell death was abrogated by depletion of TACC3. Thus, our data identify TACC3 as a potential target to overcome p21(WAF)-associated protection of transformed cells against paclitaxel-induced cell death.
Insights
Transforming acidic coiled coil (TACC) 3 depletion causes cell cycle arrest but enhances paclitaxel-induced apoptosis. TACC3 is a potential target to overcome p21(WAF)-associated resistance to chemotherapy.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Mitotic spindle regulators are key targets for cancer therapy.
- Transforming acidic coiled coil (TACC) 3 is crucial for spindle assembly and chromosome segregation.
Purpose of the Study:
- To investigate the role of TACC3 in mitotic progression and its impact on chemotherapy response.
- To determine if TACC3 can be targeted to enhance the efficacy of antitumor agents like paclitaxel.
Main Methods:
- Inducible RNA interference was used to downregulate TACC3 expression in NIH3T3 fibroblasts.
- Cell cycle progression, ploidy, apoptosis, and signaling pathways (p53-p21(WAF), Akt) were analyzed.
- TACC3-depleted and proficient cells were treated with paclitaxel.
Main Results:
- TACC3 knockdown induced aneuploidy and a reversible cell cycle arrest via the p53-p21(WAF) pathway.
- Paclitaxel induced polyploidy and apoptosis in TACC3-depleted cells, unlike in TACC3-proficient cells.
- TACC3 depletion abrogated paclitaxel-induced survival signaling (Akt, cytoplasmic p21(WAF), cyclin D1), leading to cell death.
Conclusions:
- TACC3 plays a role in protecting cancer cells from paclitaxel-induced apoptosis.
- Targeting TACC3 may overcome p21(WAF)-mediated resistance to paclitaxel in antitumor therapy.
Related Concept Videos
Drugs that Stabilize Microtubules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
